Yubo International Biotech annual operating margin
2021
2022
2023
2024
2025
Yubo International Biotech's operating margin was −9,614.64% for fiscal 2025.
View full Yubo International Biotech company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −9,614.64% | +41391.68 pp |
| 2024 | 2024-12-31 | −51,006.31% | −50808.73 pp |
| 2023 | 2023-12-31 | −197.58% | +958.15 pp |
| 2022 | 2022-12-31 | −1,155.72% | −1031.74 pp |
| 2021 | 2021-12-31 | −123.99% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | −1,299.80% | +24383.84 pp |
| Q1 2024 | 2024-03-31 | −11,737.99% | −11535.88 pp |
| Q4 2023 | 2023-12-31 | −2,854.81% | −3010.38 pp |
| Q3 2023 | 2023-09-30 | 1.50% | +1635.72 pp |
| Q2 2023 | 2023-06-30 | −25,683.64% | −19516.76 pp |
| Q1 2023 | 2023-03-31 | −202.11% | +3603.42 pp |
| Q4 2022 | 2022-12-31 | 155.57% | +507.55 pp |
| Q3 2022 | 2022-09-30 | −1,634.22% | — |
| Q2 2022 | 2022-06-30 | −6,166.88% | — |
| Q1 2022 | 2022-03-31 | −3,805.53% | — |
| Q3 2021 · Sep 30 | 2021-09-30 | −351.99% | — |
Across the available reported history, Yubo International Biotech's operating margin increased from −51,006.31% to −9,614.64%, a change of +41391.68 percentage points. The latest reported quarter, Q4 2025, shows −1,299.80%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Yubo International Biotech filings at SEC.gov ↗